Skip to main content

Day: March 11, 2022

Correction: Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.

Company announcement – No. 9 / 2022 Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022. Full Year Results for 2021 Copenhagen, March 10, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced financial results for the 12-month period from January 1 to December 31, 2021. In 2021, a number of significant milestones were accomplished by Zealand Pharma, including the U.S. Food and Drug Administration (FDA) approval of Zegalogue® (dasiglucagon) injection for the treatment of severe hypoglycemia in patients with diabetes aged six and above, and the product’s subsequent commercial...

Continue reading

Foresight Enterprise VCT plc – Issue of Equity

FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 Issue of EquityAllotment of Ordinary Shares The board of Foresight Enterprise VCT plc (“the Company”) is pleased to announce that 1,403,478 Ordinary Shares of 1p each in the capital of the Company (“the Shares”) were allotted on 11 March 2022 pursuant to the offer for subscription (“the Offer”) contained in the prospectus issued by the Company dated 11 January 2022. The Shares were issued at offer prices based on an unaudited net asset value of 67.6 pence per share ranging from 68.98 pence to 71.53 pence. Application has been made for the admission of the Shares to the Official List of the Financial Conduct Authority and to trading on London Stock Exchange plc’s market for listed securities on or around 14 March 2022. In total the Company has allotted 1,403,478 Ordinary Shares to date...

Continue reading

Kinetik Announces Closing of Upsized Secondary Offering of Common Stock

MIDLAND, Texas and HOUSTON, March 11, 2022 (GLOBE NEWSWIRE) — Kinetik Holdings Inc. (NASDAQ: KNTK) (“Kinetik” or the “Company”) announced today the closing of the upsized underwritten secondary offering of 4,000,000 shares of its Class A common stock (the “Offering”) by Apache Midstream LLC (the “Selling Stockholder”), a subsidiary of Apache Corporation, at a price of $58.00 per share, which includes the full exercise of the underwriter’s option to purchase 521,739 additional shares of Kinetik’s Class A common stock. Kinetik did not sell any shares of Class A common stock in the Offering and did not receive any proceeds from the sale of shares by the Selling Stockholder. BofA Securities, J.P. Morgan and Morgan Stanley acted as joint lead book-running managers for the Offering. Barclays, Citigroup, Credit Suisse, Goldman Sachs &...

Continue reading

PURA and PAOG Plan Sneak Peek Of CBD Nutraceutical Product Line For $17 Billion Market Opportunity

Dallas, TX, March 11, 2022 (GLOBE NEWSWIRE) — Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today announced the companies plan to publish a sneak peek next week on the coming launch of a new CBD Nutraceutical Line under PURA’s Farmersville Hemp Brand Name.  PAOG revealed in a February strategic update that the two companies were working together on a new line of CBD Nutraceuticals under PURA’s Farmersville Hemp Brand Name.  The joint CBD Nutraceutical developments have progressed, and the two companies now plan to launch the new product line next month in April. The CBD Nutraceutical market is anticipated to reach a value over $17 billion by 2026. Read PURA’s latest comprehensive update on PURA’s Farmersville Hemp Brand rollout. For more information on Puration, visit http://www.purationinc.com Learn more...

Continue reading

High Arctic Declares Recommencement of a Monthly Dividend

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, March 11, 2022 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) “High Arctic” or the “Corporation” is pleased to announce that its Board of Directors has approved the recommencement of a monthly dividend payment of $0.005 per share to holders of common shares, commencing in Q2-2022. The first dividend is payable on May 12, 2022 to holders of High Arctic common shares of record at the close of business on April 30, 2022. The ex-dividend date is April 29, 2022. The dividend is designated as an “eligible dividend” for Canadian Income Tax purposes. About High Arctic High Arctic’s principal focus is to...

Continue reading

Hudson Global Reports 2021 Fourth Quarter and Full-Year Results

OLD GREENWICH, Conn., March 11, 2022 (GLOBE NEWSWIRE) — Hudson Global, Inc. (Nasdaq: HSON), a leading global talent solutions company, announced today financial results for the fourth quarter and full year ended December 31, 2021. 2021 Fourth Quarter SummaryRevenue of $50.1 million increased 83.2% from the fourth quarter of 2020, or 82.9% in constant currency.Adjusted net revenue of $22.3 million increased 97.8% from the fourth quarter of 2020, or 97.1% in constant currency.Net income of $2.1 million, or $0.70 per basic and $0.67 per diluted share, versus net income of $1.2 million, or $0.41 per basic and diluted share, in the fourth quarter of 2020. Adjusted net income per diluted share (Non-GAAP measure)* increased to $1.02 from adjusted net income per diluted share of $0.20 in the fourth quarter of 2020.Adjusted EBITDA...

Continue reading

Ferrellgas Partners, L.P. Reports Second Quarter Fiscal 2022 Results

Financial HighlightsRevenues for the second fiscal quarter increased $131.4 million or 24% to $684.9 million, compared to $553.5 million in the prior year period. Gross Profit increased $18.9 million or 7% to $298.2 million, compared to $279.3 million in the prior year period. Operating Income increased by $20.3 million or 18% to $134.9 million, compared to $114.6 million in the prior year period.Company HighlightsFerrellgas announced the expansion of its partnership with Operation BBQ Relief. Blue Rhino teamed up with International Rhino Foundation to raise awareness of rhino conservation efforts. Blue Rhino home delivery entered Long Island market. The Company celebrated 280 Ferrellgas employees recognized in the areas of: Customer Service, Safety, Innovation and Leadership via the Ferrellgas Flame Awards.LIBERTY, Mo., March...

Continue reading

Alpha Copper Makes First Payment to Acquire Okeover Copper Project

VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Alpha Copper Corp. (“Alpha Copper” or the “Company”) (CSE: ALCU) (OTC: ALCUF) is pleased to announce that, further to its news release dated January 14, 2022 (together, the “Prior Release”), the Company has made its first issuance under the option agreement (the “Option Agreement”) dated January 13, 2022 among Eastfield Resources Ltd., Northwest Copper Corp. (“Northwest”) and the Company, pursuant to which the Company may acquire a 100% interest (the “Acquisition”) in the Okeover Copper Project located in British Columbia (the “Property”). In accordance with the Option Agreement, the Company issued 267,159 common shares (the “Payment Shares”) to Northwest, having an aggregate deemed value of $250,000. The Payment Shares are subject to a statutory hold period of four...

Continue reading

SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results

Provides 2022 Revenue Guidance CARLSBAD, Calif., March 11, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2021. Summary Fourth Quarter 2021 Financial Results and Recent AccomplishmentsRevenue of $55.6 million, an increase of 20% year-over-year U.S. revenue of $50.2 million, an increase of 19% year-over-yearU.S. spinal implants and enabling technologies revenue of $27.3 million, an increase of 32% year-over-year U.S. orthobiologics revenue of $22.9 million, an increase of 7% year-over-yearInternational revenue of $5.4 million, an increase of 26% year-over-year Completed integration of 7D Surgical Initiated full...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.